| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Rein Therapeutics, Inc. (RNTX) has 6 insiders with recent SEC Form 4 filings, including 5 buys and 12 sells. RNTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 926.4K | $879.3K | - | |
| Dir | 17.5K | $16.6K | - | |
| Dir | 17.5K | $16.6K | - | |
| Dir | 17.5K | $16.6K | - | |
| Dir | 17.5K | $16.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2019 | Gregory Kathryn | SVP, Chief Business Officer | Buy | 45,000 | $0.65 | $29,025.00 | New | |
| Aug 10, 2018 | Longenecker John P Phd | President And CEO | Buy | 10,000 | $2.45 | $24,500.00 | New | |
| Jun 26, 2018 | Apple Tree Partners II LP | 10% Owner | Sell | 106,257 | $5.92 | $629,521.66 | -2.5% | |
| Jun 21, 2018 | Apple Tree Partners II LP | 10% Owner | Sell | 6,647 | $5.30 | $35,232.74 | -0.2% | |
| Jun 19, 2018 | Apple Tree Partners II LP | 10% Owner | Sell | 9,532 | $5.32 | $50,743.26 | -0.2% | |
| Jun 12, 2018 | Apple Tree Partners II LP | 10% Owner | Sell | 10,843 | $5.40 | $58,557.62 | -0.7% | |
| Jun 11, 2018 | Apple Tree Partners II LP | 10% Owner | Sell | 28,162 | $5.41 | $152,314.55 | -0.6% | |
| Jun 8, 2018 | Dougherty Donald | SVP &Chief Financial Officer | Buy | 3,000 | $5.40 | $16,200.00 | +150.0% | |
| Jun 6, 2018 | Aivado Manuel | See Remarks | Buy | 1,000 | $5.61 | $5,610.00 | New | |
| Jun 1, 2018 | Dougherty Donald | SVP &Chief Financial Officer | Buy | 2,000 | $5.24 | $10,480.00 | New |